Eravacycline Dihydrochloride and Eslicarbazepine Acetate

• Generic Name: eravacycline
• Dosage Forms: n.a.
• Other Brand Names: Xerava

Eravacycline dihydrochloride is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI) in patients 18 years of age and older.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of eravacycline dihydrochloride and other antibacterial drugs, eravacycline dihydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

Eravacycline dihydrochloride is not indicated for the treatment of complicated urinary tract infections (cUTI).

• Generic Name: eslicarbazepine
• Dosage Forms: n.a.
• Other Brand Names: Aptiom

Management (in combination with other anticonvulsants) of partial-onset seizures in adults.

In longer-term extension studies, reductions in seizure frequency were maintained for at least 1 year.

Controlled comparative trials between eslicarbazepine acetate and oxcarbazepine needed to fully evaluate the relative efficacy and tolerability of these structurally related anticonvulsants (see Actions).

Once-daily dosage regimen may help improve patient compliance.